Role of calbindin-D28K in estrogen treatment for Parkinson's disease

被引：6

作者：

Wane, Chunhua ^{[1
,2
,3
]}

Jiang, Chao ^{[1
]}

Yuan, Honghua ^{[1
]}

Xiao, Chenghua ^{[2
]}

Gao, Dianshuai ^{[1
,2
]}

机构：

[1] Xuzhou Med Coll, Dept Neurobiol, Xuzhou 221002, Jiangsu, Peoples R China

[2] Xuzhou Med Coll, Dept Neurol, Xuzhou 221002, Jiangsu, Peoples R China

[3] Funing Cty Peoples Hosp, Dept Neurol, Yancheng 224400, Jiangsu, Peoples R China

来源：

NEURAL REGENERATION RESEARCH | 2013年 / 8卷 / 08期

关键词：

neural regeneration; neurodegenerative diseases; estrogen; calbindin-D28K; Parkinson's disease; dopaminergic neuron; tyrosine hydroxylase; photographs-containing paper; neuroregeneration; MPTP MOUSE MODEL; DOPAMINERGIC-NEURONS; SIGNALING PATHWAY; G-PROTEIN; ESTRADIOL; INVOLVEMENT; EXPRESSION; BINDING; KINASE; 17-BETA-ESTRADIOL;

D O I：

10.3969/j.issn.1673-5374.2013.08.004

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Studies have shown that estrogen has neuroprotective effects on the nigrostriatal system. The present study established a Parkinson's disease model in C57BL/6 mice by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrapyridine. The mice were subjected to 17 beta estradiol injection into the lateral ventricle. Immunofluorescence double staining showed that estrogen increased tyrosine hydroxylase and calbindin-D28K expression and co-expression in dopaminergic neurons of midbrain substantia nigra pars compacta of model mice. Behavior experiments showed that estrogen improved swimming and hanging behaviors in this mouse model of Parkinson's disease.

引用

页码：702 / 707

页数：6

共 39 条

[1] From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens
Amantea, D
Russo, R
Bagetta, G
Corasaniti, MT
[J]. PHARMACOLOGICAL RESEARCH, 2005, 52 (02) : 119 - 132
[2] Myo-inositol monophosphatase is an activated target of calbindin D28k
Berggård, T
Szczepankiewicz, O
Thulin, E
Linse, S
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) : 41954 - 41959
[3] 17-β estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain
Bryant, DN
Bosch, MA
Ronnekleiv, OK
Dorsa, DM
[J]. NEUROSCIENCE, 2005, 133 (01) : 343 - 352
[4] The involvement of NF-κB p65/p52 in the effects of GDNF on DA neurons in early PD rats
Cao, Jun Ping
Wang, Hong Jun
Yu, Jing Kao
Liu, Hong Mei
Gao, Dian Shuai
[J]. BRAIN RESEARCH BULLETIN, 2008, 76 (05) : 505 - 511
[5] Involvement of NCAM in the effects of GDNF on the neurite outgrowth in the dopamine neurons
Cao, Jun-Ping
Wang, Hong-Jun
Yu, Jing-Kao
Yang, Hua
Xiao, Cheng-Hua
Gao, Dian-Shuai
[J]. NEUROSCIENCE RESEARCH, 2008, 61 (04) : 390 - 397
[6] Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity
Choi, Won-Seok
Lee, Eunhee
Lim, Junghyun
Oh, Young J.
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 371 (01) : 127 - 131
[7] Biological actions and mechanism of action of calbindin in the process of apoptosis
Christakos, S
Liu, Y
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) : 401 - 404
[8] Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice
D'Astous, M
Mendez, P
Morissette, M
Garcia-Segura, LM
Di Paolo, T
[J]. MOLECULAR PHARMACOLOGY, 2006, 69 (04) : 1492 - 1498
[9] Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity
Dluzen, DE
McDermott, JL
[J]. CURRENT STATUS OF DRUG DEPENDENCE / ABUSE STUDIES: CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY, 2004, 1025 : 205 - 220
[10] Estrogen as neuroprotectant of nigrostriatal dopaminergic system - Laboratory and clinical studies
Dluzen, DE
Horstink, MWIM
[J]. ENDOCRINE, 2003, 21 (01) : 67 - 75

← 1 2 3 4 →